HomeStreet and FirstSun called off the merger in November, with commercial real estate exposure as a hot topic moving forward ...

The videogame retailer’s shares jumped following the latest cryptic post from influential trader Keith Gill, aka “Roaring ...

Dan Ives, Wedbush global head of technology research, joins 'Closing Bell: Overtime' to discuss Salesforce after the ...

What makes that call particularly surprising is that most pundits are still skeptical about Palantir. Among the 20 analysts ...

Musk reacted on his X social media platform to the ruling on Monday by Court of Chancery Judge Kathleen McCormick.

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

GameStop Corp (GME) stock saw a modest uptick, ending the day at $29.06 which represents a slight increase of $0.43 or 1.50% from the prior close of $28.63. The stock opened at $29.12 and touched a ...

Wedbush’s price target would suggest a potential upside of 3.05% from the company’s previous close. A number of other brokerages also recently issued reports on UPST.

Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) – Analysts at Wedbush cut their Q3 2025 earnings per share estimates for Apogee Therapeutics in a research note issued on Monday ...

Wedbush analyst Seth Basham reiterated a Buy rating on Chewy (CHWY – Research Report) today and set a price target of $39.00. The company’s shares opened today at $32.78. Don't Miss our Black Friday ...

Invent, its annual all things cloud related conference, last week, which provided positive implications. Read more here.